Press Release

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text] IDENTIFY PH presented at ATS Washington DC—May 21, 2023—CorVista Health, Inc, a leading digital health company dedicated to improving cardiovascular disease diagnosis, announces the presentation of a machine-learned algorithm to IDENTIFY PH at the American Thoracic Society (ATS) (ML)...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text] IDENTIFY Study Results Published in PLOS ONE Washington DC—November 17, 2022—CorVista Health, Inc, a digital health company dedicated to improving cardiovascular disease diagnosis, announces the publishing of the IDENTIFY Study in PLOS ONE, the multicenter validation...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text]Washington DC—October 25, 2022—CorVista Health, Inc, a digital health company dedicated to improving cardiovascular disease diagnosis, announces that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the CorVista System as a first...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text] Washington, DC, June 8, 2022 — CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, announces the expansion of their Medical Advisory Board with the appointment of Drs. Vallerie V. McLaughlin and Mark G. Rabbat. ...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text] Also Appointed to Board of Directors of The Forsyth Institute Washington, DC, February 16, 2022 — CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, announces the election of Dr. Charles Bridges to the...